USD
+$0.00
(+0.00%
)At Close (As of Sep 8, 2025)
$19.00M
Market Cap
-
P/E Ratio
-2.23
EPS
$4.20
52 Week High
$1.87
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $1M |
Total Revenue | $1M |
Cost Of Revenue | $174K |
Costof Goods And Services Sold | $174K |
Operating Income | -$22M |
Selling General And Administrative | $12M |
Research And Development | $11M |
Operating Expenses | $23M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $174K |
Income Before Tax | -$21M |
Income Tax Expense | -$798K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$20M |
Comprehensive Income Net Of Tax | - |
Ebit | -$22M |
Ebitda | -$22M |
Net Income | -$20M |
Field | Value (USD) |
---|---|
Total Assets | $35M |
Total Current Assets | $35M |
Cash And Cash Equivalents At Carrying Value | $16M |
Cash And Short Term Investments | $16M |
Inventory | - |
Current Net Receivables | $900K |
Total Non Current Assets | $424K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $192K |
Intangible Assets Excluding Goodwill | $192K |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $15M |
Other Current Assets | $2.4M |
Other Non Current Assets | - |
Total Liabilities | $5.7M |
Total Current Liabilities | $5.6M |
Current Accounts Payable | $1.3M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $274K |
Total Non Current Liabilities | $72K |
Capital Lease Obligations | $137K |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $137K |
Other Current Liabilities | $4.1M |
Other Non Current Liabilities | $72K |
Total Shareholder Equity | $30M |
Treasury Stock | - |
Retained Earnings | -$548M |
Common Stock | $8K |
Common Stock Shares Outstanding | $8.3M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$19M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $174K |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $13M |
Cashflow From Financing | -$206K |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$20M |
Field | Value (USD) |
---|---|
Gross Profit | $1M |
Total Revenue | $1M |
Cost Of Revenue | $174K |
Costof Goods And Services Sold | $174K |
Operating Income | -$22M |
Selling General And Administrative | $12M |
Research And Development | $11M |
Operating Expenses | $23M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $174K |
Income Before Tax | -$21M |
Income Tax Expense | -$798K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$20M |
Comprehensive Income Net Of Tax | - |
Ebit | -$22M |
Ebitda | -$22M |
Net Income | -$20M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing cellular therapies to reverse disease and/or promote regeneration of damaged tissue. The company is headquartered in Basking Ridge, New Jersey.